Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of gemcitabine plus cisplatin versus fluorouracil plus cisplatin in the first-line setting for Chinese patients with metastatic nasopharyngeal carcinoma.
Jin, Chaohui; Zheng, Hanrui; Zhan, Mei; Wen, Feng; Xu, Ting.
Afiliação
  • Jin C; Department of Clinical Pharmacy, West China Hospital, Sichuan University, Chengdu, China.
  • Zheng H; Department of Clinical Pharmacy, West China Hospital, Sichuan University, Chengdu, China.
  • Zhan M; Department of Clinical Pharmacy, West China Hospital, Sichuan University, Chengdu, China.
  • Wen F; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Xu T; West China Biostatistics and Cost-Benefit Analysis Center, Sichuan University, Chengdu, China.
Eur Arch Otorhinolaryngol ; 277(2): 577-584, 2020 Feb.
Article em En | MEDLINE | ID: mdl-31720816
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Nasofaríngeas / Cisplatino / Desoxicitidina / Fluoruracila / Carcinoma Nasofaríngeo Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Nasofaríngeas / Cisplatino / Desoxicitidina / Fluoruracila / Carcinoma Nasofaríngeo Idioma: En Ano de publicação: 2020 Tipo de documento: Article